Antithrombotische Therapie für kardiologische Eingriffe bei Patienten mit Thrombozytopenie bei onkologischen Erkrankungen: Konsensuspapier der Arbeitsgruppe „Kardiovaskuläre Hämostase und antithrombotische Therapie“ (AG19) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e. V. (DGTI), der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie e. V. (DGHO) und der Gesellschaft für Thrombose und Hämostaseforschung e. V. (GTH)

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • David Naguib - , University Hospital Duesseldorf (Author)
  • Tamam Bakchoul - , University Hospital Tübingen (Author)
  • Sascha Dietrich - , University Hospital Duesseldorf (Author)
  • Tobias Geisler - , University Hospital Tübingen (Author)
  • Holger Hackstein - , Friedrich-Alexander University Erlangen-Nürnberg (Author)
  • Alexander Kille - , University Medical Center Freiburg (Author)
  • Steffen Koschmieder - , RWTH Aachen University, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) (Author)
  • Lorenz H. Lehmann - , Heidelberg University  (Author)
  • Axel Linke - , Department of Internal Medicine and Cardiology (at Dresden Heart Centre), University Hospital Carl Gustav Carus Dresden, German Society for Cardiology – Heart and Circulation Research (DGK) (Author)
  • Tobias Petzold - , Charité – Universitätsmedizin Berlin (Author)
  • Roman Pfister - , University of Cologne (Author)
  • Christoph B. Olivier - , University Medical Center Freiburg (Author)
  • Heiko Rühl - , University of Bonn (Author)
  • Andreas Tiede - , Hannover Medical School (MHH) (Author)
  • Karolin Trautmann-Grill - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Willibald Hochholzer - , Clinic Würzburg Mitte gGmbH (Author)
  • Amin Polzin - , University Hospital Duesseldorf (Author)

Abstract

Antithrombotic treatment is the backbone to prevent ischemic events in interventional cardiology; however, antithrombotic medication enhances the risk of bleeding. Oncological diseases are frequently associated with thrombocytopenia. The optimal antithrombotic regimen if these patients undergo interventional procedures is unknown. Hence, this consensus statement aims to provide a clinical guide to antithrombotic treatment options in these patients. As there are no sufficient data these recommendations are based on expert opinions.

Translated title of the contribution
Antithrombotic treatment for cardiological interventions in patients with thrombocytopenia in oncological diseases
Consensus paper of the Working Group on Cardiovascular Hemostasis and Antithrombotic Treatment (AG19) of the German Cardiac Society (DGK), the German Society for Transfusion Medicine and Immunohematology (DGTI), the German Society for Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Haemostasis Research (GTH)

Details

Original languageGerman
Pages (from-to)455-463
Number of pages9
JournalKardiologie
Volume19
Issue number6
Publication statusPublished - Dec 2025
Peer-reviewedYes

Keywords

ASJC Scopus subject areas

Keywords

  • Acute coronary syndrome, Anticoagulation, Antithrombotic treatment, Interventional cardiology, Percutaneous coronary intervention